Applewhaite F, Ginsberg V, Gerena J, et al. A very frequent red cell antigen, Ata. Vox Sang 1967;13:444–5.10.1111/j.1423-0410.1967.tb03789.x6050732Search in Google Scholar
Gellerman MM, McCreary J, Yedinak E, Stroup M. Six additional examples of anti-Ata. Transfusion 1973;13:225–30.10.1111/j.1537-2995.1973.tb05479.x4541728Search in Google Scholar
Frank S, Schmidt RP, Baugh M. Three new antibodies to high-incidence antigenic determinants (anti-El, anti-Dp, and anti-So). Transfusion 1970;10:254–7.10.1111/j.1537-2995.1970.tb00739.x4097024Search in Google Scholar
Brown A, Harris P, Daniels GL, Frank S, Moore BPL, Berger R. Ata (August) and El (Eldr) are synonymous. Transfusion 1983;44:123–5.Search in Google Scholar
Daniels G, Bailif BA, Helias V, et al. Lack of nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization. Blood 2015;125:3651–4.10.1182/blood-2015-03-631598445880325896650Search in Google Scholar
Storry JR, Castilho L, Chen Q, et al. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Terminology: Report of the Seoul and London meetings. ISBT Sci Ser 2016;11:118–22.10.1111/voxs.12280566201029093749Search in Google Scholar
Winkler MM, Hamilton JR. Previously tested donors eliminated to determine rare phenotype frequencies [abstract]. In: Proc 21st Joint Congr Int Soc Blood Transfus Am Ass Blood Banks 1990:158.Search in Google Scholar
Vengelen-Tyler V. Efficient use of scarce sera in screening thousands of donors [abstract]. Transfusion 1985;25:476.Search in Google Scholar
Sweeney JD, Holme S, McCall L, et al. At(a–) phenotype: description of a family and reduced survival of At(a+) red cells in a proposita with anti-Ata. Transfusion 1995:35:63–7.10.1046/j.1537-2995.1995.35195090666.x7998074Search in Google Scholar
Ramsey G, Sherman LA, Zimmer AM, et al. Clinical significance of anti-Ata. Vox Sang 1995;69:135–7.10.1111/j.1423-0410.1995.tb01684.x8585195Search in Google Scholar
Cash K, Brown T, Sausais L, et al. Severe delayed hemolytic transfusion reaction secondary to anti-Ata. Transfusion 1999; 39:834–7.10.1046/j.1537-2995.1999.39080834.x10504118Search in Google Scholar
Daniels G. Human blood groups. 3rd ed. Oxford, UK: Wiley-Blackwell, 2013.10.1002/9781118493595Search in Google Scholar
Reid ME, Lomas-Francis C, Olsson ML. The blood group antigen factsbook. 3rd ed. London, UK: Elsevier, 2012.10.1016/B978-0-12-415849-8.00026-0Search in Google Scholar
Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting clinical significance of blood group alloantibodies. Transfusion 2004;44:1273–81.10.1111/j.1537-2995.2004.03427.x15318848Search in Google Scholar
Culver PL, Brubaker DB, Sheldon RE, et al. Anti-Ata causing mild hemolytic disease of the newborn. Transfusion 1987;27:468–70.10.1046/j.1537-2995.1987.27688071696.x3686655Search in Google Scholar
McBean R, Liew Y-W, Wilson B, et al. Genotyping confirms inheritance of the rare At(a–) type in a case of haemolytic disease of the newborn. J Pathol Clin Res 2016;2:53–5.10.1002/cjp2.33485812427499913Search in Google Scholar
Griffiths M, Beaumont N, Yao SY, et al. Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nat Med 1997;3: 89–93.10.1038/nm0197-898986748Search in Google Scholar
Young JD, Yao SY, Sun L, et al. Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica 2008;38:995–1021.10.1080/0049825080192742718668437Search in Google Scholar
Grenz A, Bauerle JD, Dalton JH, et al. Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. J Clin Invest 2012;122:693–710.10.1172/JCI60214326679222269324Search in Google Scholar
Mediero A, Cronstein BN. Adenosine and bone metabolism. Trends Endocrinol Metab 2013;24:290–300.10.1016/j.tem.2013.02.001366966923499155Search in Google Scholar
Warraich S, Bone DB, Quinonez D, et al. Loss of equilibrative nucleoside transporter 1 in mice leads to progressive ectopic mineralization of spinal tissues resembling diffuse idiopathic skeletal hyperostosis in humans. J Bone Miner Res 2013;28:1135–49.10.1002/jbmr.182623184610Search in Google Scholar
Hinton DJ, McGee-Lawrence ME, Lee MR, et al. Aberrant bone density in aging mice lacking the adenosine transporter ENT1. PLoS One 2014;9:e88818.10.1371/journal.pone.0088818392949324586402Search in Google Scholar
Endres CJ, Moss AM, Ke B, et al. The role of the equilibrative nucleoside transporter 1 (ENT1) in transport and metabolism of ribavirin by human and wild-type or Ent1–/– mouse erythrocytes. J Pharmacol Exp Ther 2009;329:387–98.10.1124/jpet.108.145854267059319164463Search in Google Scholar
Ibarra KD, Pfeiffer JK. Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance. J Virol 2009;83:4538–47.10.1128/JVI.02280-08266847819244331Search in Google Scholar
